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Regulation of zygotic gene expression in Drosophila primordial
germ cells
Mark Van Doren, Anne L. Williamson* and Ruth Lehmann
Activation of the zygotic genome is a prerequisite for
the transition from maternal to zygotic control of
development. The onset of zygotic transcription has
been well studied in somatic cells, but evidence
suggests that it is controlled differently in the germline.
In Drosophila, zygotic transcription in the soma has
been detected as early as one hour after egg laying
(AEL) [1]. In the germline, general RNA synthesis is not
detected until 3.5 hours AEL (stage 8) [2] and poly(A)-
containing transcripts are not observed in early germ
cell nuclei [3]. However, rRNA gene expression has
been demonstrated at this time [4]. Therefore, either
there is a general, low level activation of the genome in
early germ cells, or specific classes of genes, such as
those transcribed by RNA polymerase (RNAP) II, are
repressed. We addressed this issue by localizing the
potent transcriptional activator Gal4–VP16 to the
germline, and we find that Gal4–VP16-dependent gene
expression is repressed in early germ cells. In addition,
localization of germ plasm to the anterior reveals that it
is sufficient to repress Bicoid-dependent gene
expression. Thus, even in the presence of known
transcriptional activators, RNAP II dependent gene
expression is actively repressed in early germ cells.
Furthermore, once the germ cell genome is activated,
we find that vasa is expressed specifically in germ cells.
This expression does not require proper patterning of
the soma, indicating that it is likely to be controlled by
the germ plasm.
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Results and discussion
Repression of gene expression in the germline
To determine whether expression of genes transcribed by
RNAP II is actively repressed in Drosophila germ cells, we
asked whether a transcriptional activator could induce
expression of a known target gene in these cells. As we are
not aware of an endogenous transcription factor in
Drosophila germ cells with a defined target gene, we local-
ized the potent transcriptional activator Gal4–VP16 [5] to
the germ cells and examined the expression of a
Gal4–VP16-responsive target gene (Figure 1). We
expressed RNA encoding Gal4–VP16 maternally using the
nanos (nos) promoter and localized it to the germ cells
using the untranslated region (UTR) of the nos RNA
(Figure 1a). The nos gene is expressed during oogenesis
[6], and the 3′ UTR of the nos RNA is sufficient to localize
it to the posterior pole of the embryo [7] and restrict its
translation to the posterior pole [8]. Nos protein forms a
gradient with the highest levels at the posterior pole, and
both the nos RNA and Nos protein are taken up into germ
cells as they form [6]. By replacing the nos coding region
with Gal4–VP16, we have localized RNA encoding
Gal4–VP16 to the posterior pole (Figure 1b) and germ
cells (not shown), which are highly active for translation at
this time [2]. For a Gal4–VP16-responsive target, we used
an upstream activation sequence (UAS)–lacZ transgene
[9], which contains Gal4-binding sites upstream of a hsp70
minimal promoter and the lacZ coding region. 
As shown in Figure 1c, the UAS–lacZ transgene is
expressed in somatic cells in the posterior region of the
embryo. This is as expected if, like Nos, Gal4–VP16 is
translated at the posterior pole to form a posterior to ante-
rior concentration gradient. In contrast, the germ cells
show no detectable expression of the UAS–lacZ target
gene (Figure 1c inset), indicating that Gal4–VP16-depen-
dent gene expression is repressed in these cells. We first
see cytoplasmic accumulation of lacZ RNA in germ cells at
~3.5 hours AEL (stage 8–9; Figure 1d). This is ~2 hours
after zygotic gene expression is first detected in somatic
nuclei [1], in agreement with the time that Zalokar [2]
observed an increase in total RNA synthesis in germ cells.
We conclude that Gal4–VP16-dependent expression of
the UAS–lacZ target gene is repressed in germ cells rela-
tive to somatic cells.
We next asked whether the repression of gene expression
in the germ cells is conferred by the germ plasm and is
downstream of oskar (osk). In addition, we wanted to
determine whether target genes for an endogenous
Drosophila transcription factor would be repressed in the
germline. Normally, osk RNA is localized to the posterior
pole, where it is essential for germ plasm assembly.
Localization of osk RNA to the anterior of the embryo
using the osk–bcd-3′ UTR transgene is sufficient to
promote formation of anterior germ cells [10]. As the
maternal transcription factor Bicoid (Bcd) normally forms
an anterior to posterior protein gradient with the highest
protein levels at the anterior pole (Figure 2a) [11], we
could examine the expression of Bcd target genes in
these anterior germ cells. It has been shown that Bcd is a
direct transcriptional activator of hunchback (hb) [12,13].
Furthermore, synthetic reporter constructs with high-
affinity Bcd-binding sites upstream of a hsp70 minimal
promoter and lacZ coding sequences (Hb3Bcd3–lacZ) are
sensitive reporters of Bcd activity [14]. We tested the
effect of germ plasm on the expression of hb and the
Hb3Bcd3–lacZ reporter. To maximize Bcd activity, we
performed these experiments in a genetic background
that removes known translational repression of bcd by Nos
[7,15] and post-translational regulation of Bcd by the ter-
minal pathway (torsolike, tsl) [16]. In addition, this genetic
background ensures that the anterior of the embryo is not
transformed to a posterior identity by the ectopic osk, so
that the anterior germ cells are truly in a somatic environ-
ment that is different from where they normally form. 
In the absence of anterior osk, both the endogenous hb
gene and the Hb3Bcd3–lacZ transgene are expressed at
high levels in the anterior region, including the anterior
pole (Figure 2c,e). When osk is localized to the anterior,
maternal Bcd protein is present at high levels in the germ
cells that form there (Figure 2b). However, neither the
endogenous hb gene nor the Hb3Bcd3–lacZ transgene are
expressed in the anterior germ cells, though they are
expressed in anterior somatic cells (Figure 2d,f). Thus osk-
nucleated germ plasm is sufficient to confer repression of
Bcd-responsive target genes in anterior cells.
We have therefore observed repression of gene expression
in the germline with the endogenous Drosophila transcrip-
tion factor Bcd acting on its target gene hb, and also with
the exogenous transcription factor Gal4–VP16 and syn-
thetic target genes. Repression of an exogenous transcrip-
tion factor and synthetic target genes suggests that this
effect may be general in nature, rather than promoter spe-
cific, and may apply broadly to RNAP II dependent gene
expression. Interestingly, expression of genes transcribed
by RNAP I does not appear to be repressed in the
Drosophila germline [4]. Therefore the mechanism is not
so general as to affect transcription universally, as might
be the case if the DNA was in a conformation incompati-
ble with transcription. 
Repression of gene expression in the germline has also
been described in Caenorhabditis elegans. The pie-1 gene
is essential for repression of somatic gene expression in
the C. elegans germline, and ectopic expression of PIE-1
in somatic cells is sufficient to repress gene expression
in those cells [17]. As in Drosophila, RNAP I transcrip-
tion is not affected in the C. elegans germline [4].
Although RNAP II is present in the germlines of C.
elegans and Drosophila embryos, both lack a specific
phosphoform of the enzyme [4] that may either cause or
result from repression of RNAP II transcription. Inter-
estingly, this phosphoform appears in the Drosophila
germline at stage 7 (3 hours AEL [4]), which is just prior
to when we first observe zygotic gene expression in
these cells (3.5 hours AEL; Figure 1). Although it is pos-
sible that repression of gene expression in the germline
is caused by decreased RNA stability, the changes in
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Figure 1
Expression of a Gal4–VP16-responsive target
gene is repressed in the germline relative to
the soma. Anterior is to the left. (a) Diagram
showing the nos–Gal4–VP16 transgene and
localization of Gal4–VP16 to the germ cells
(pole cells, pc). (b) In situ hybridization of a
pre-blastoderm embryo from a
nos–Gal4–VP16 transgenic mother using an
antisense probe recognizing Gal4–VP16 but
not nos sequences: nos–Gal4–VP16 RNA is
localized to the posterior pole. (c,d) In situ
hybridization with an antisense lacZ riboprobe
of embryos from nos–Gal4–VP16 transgenic
females crossed to UAS–lacZ transgenic
males. (c) Early gastrula (stage 6, ~3 h AEL).
Note that the posterior somatic cells express
lacZ RNA whereas the germ cells do not
(enlarged in inset). (d) Stage 9 embryo (~4 h
AEL). The germ cells now express lacZ RNA.
Similar results were obtained with two
different UAS–lacZ transgenic lines, and no
expression is seen from these lines in the
absence of the nos–Gal4–VP16 transgene.
We have been unable to detect the
Gal4–VP16 protein by whole-mount
immunohistochemistry using a variety of
antibodies, even in regions where Gal4–VP16
activity is clearly detectable. However, the
nos–Gal4–VP16 RNA disappears soon after
the germ cells form (data not shown),
indicating that the activity of the Gal4–VP16
protein observed later in the germ cells arises
from translation of the nos–Gal4–VP16 RNA














RNAP II suggest that the mechanism is more likely to
be at the level of transcription.
Activation of germline-specific gene expression
The repression of germline gene expression must eventu-
ally be overcome so that germ cells can express the genes
required for their unique developmental program. We
therefore wanted to address how zygotic gene expression
is activated in the germline and how germ cell specific
gene expression is regulated. We found that the vasa (vas)
gene [18,19] is expressed specifically in germ cells begin-
ning at stage 9 (~4 hours AEL; Figure 3a). This is very
soon after the time that germ cells become competent for
expression of RNAP II target genes as judged by our
experiments with Gal4–VP16 (Figure 1). To our knowl-
edge, vas represents the earliest example of RNAP II
dependent gene expression in the Drosophila germline.
Communication between somatic cells and germ cells is
essential for proper germ cell migration and development
(reviewed in [20]). Therefore, signals from somatic tissue
might regulate vas expression in the germ cells. Because
the germ cells are contained within the posterior midgut
pocket at the time at which we first see vas expressed, we
determined whether the correct identity of this tissue is
required for vas expression. The vas gene is still
expressed specifically in germ cells of mutants that lack a
posterior midgut and hindgut (tailless huckebein and tsl;
data not shown, but see Figure 3c). Another candidate for
providing somatic signals to the germ cells is the meso-
derm, as it lies adjacent to the midgut and is the target
tissue for germ cell migration. However, vas expression is
also unaffected in embryos that lack mesoderm (twist
snail, twi sna; Figure 3b). Finally, we examined embryos
in which all three systems for initiating anterior–posterior
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Figure 2
Localization of osk RNA to the anterior pole
results in repression of Bcd target gene
expression. All panels show stage 5 embryos
derived from nos tsl double mutant females
crossed to males containing the
Hb3Bcd3–lacZ transgene. For panels (b,d,f),
the females also contained the osk–bcd-
3′ UTR transgene, which localizes osk RNA to
the anterior pole and directs the formation of
anterior germ cells. Anterior is to the left. (a,b)
Embryos stained with anti-Bcd antibody. In
(b), high levels of Bcd protein are present in
the nuclei of germ cells formed at the anterior.
(c,d) Embryos stained by in situ hybridization
to hb RNA. (e,f) Embryos stained by in situ
hybridization to lacZ RNA. In both (d) and (f),
the anterior germ cells do not express the Bcd












Zygotic vas expression. All panels show in situ hybridization to vas
RNA. (a) Stage 9 wild-type embryo (~4 h AEL). Zygotic expression of
vas RNA is detected specifically in germ cells beginning at this time.
The more general staining observed is still present in embryos of the
genotype Df(2L)A267/Df(2L)TE36 GW29, in which both copies of
the vas gene have been deleted, and therefore does not represent
zygotic vas expression. Germ cell staining is absent from these
embryos. (b) A twi sna double mutant embryo lacking all mesoderm.
The germ cells still express vas RNA. (c) Embryo from a female bcd
nos tsl triple mutant. These embryos develop no anterior–posterior
pattern. The cells expressing zygotic vas RNA were identified as germ
cells by the presence of Vas protein (data not shown), which is still
localized maternally to the germ cells in this genetic background.
pattern have been removed (bcd nos tsl) and found that vas
is still expressed specifically in germ cells (Figure 3c).
Therefore, germ cell specific vas expression does not
require proper specification of the endoderm or meso-
derm and occurs even in the absence of anterior–posterior
somatic patterning.
Implications for the germ plasm
Our results support the hypothesis that repression of germ
cell gene expression, as well as its activation at the appro-
priate time and in a germ cell specific manner, are all con-
trolled maternally by the germ plasm. In this model, at
least one maternally supplied transcription factor would be
localized to the germ cells, perhaps in a manner analogous
to our nos–Gal4–VP16 transgene, and would activate
germline-specific targets once the germline is competent
for gene expression. The vas gene is a candidate for being
directly responsive to such a transcription factor. In addi-
tion, a mechanism for timing the onset of zygotic gene
expression in the germline would also be provided mater-
nally and be autonomous to the germ cells. Indeed, even
germ cells isolated in culture appear to exhibit the normal
program of germ cell specific repression and activation of
RNA synthesis [21]. It is unlikely that the mechanism for
activating the zygotic genome involves the nuclear to
cytoplasmic ratio, as has been found for the soma [1],
because germ cells stop dividing well before they initiate
gene expression [22]. Finally, germ cells exhibit a variety
of other behaviors prior to the time that they are compe-
tent for zygotic gene expression, including precocious cel-
lularization [22], germ cell specific cell cycle regulation
[22], translational regulation [23] and development of a
migratory cellular morphology [24]. Thus, the germ plasm
must contain a combination of factors controlling both the
cellular behaviors of the early germ cells and the activation
of primordial germ cell specific gene expression.
Materials and methods
The following stocks were used in this study: nosBN tsl691, nosL7 bcdE1
tsl146, Df(2L)A267 (vas–), Df(2L)TE36 GW29 (vas–), tllg hkbX179 (a
gift from Herbert Jäckle), and twiIIH snaIIG. UAS–lacZ lines Bg4-1-2
and Bg4-2-46 were a gift from Norbert Perrimon [9], and
Hb3Bcd3–lacZ line HSBGHbBcd3C was a gift from Nathalie Dostatni,
Jessica Treisman and Claude Desplan [14]. To generate the
nos–Gal4–VP16 transgene, the nos coding sequences within a deriva-
tive of pHSXgnosbR [7] were replaced with sequences encoding the
FLAG epitope tag (IBI) and Gal4–VP16 [5], and the construct contains
approximately 700 bp of the nos promoter, the nos 5′ and 3′ UTRs,
and approximately 500 bp of genomic sequence 3′ of nos (further
details available upon request). The transgenic line used shows no
defects in germline development. In situ hybridization and whole-mount
antibody staining of embryos were performed as described [7]. Mouse
monoclonal anti-Bcd antibody was a gift from Wolfgang Driever.
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